vTv Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:VTVT   12:59:56 PM EDT
1.34
-0.03 (-2.19%)
Earnings Announcements

vTv Therapeutics Reports Q3 Loss Per Share Of $0.02

Published: 11/09/2021 14:02 GMT
vTv Therapeutics Inc - Ordinary Shares - Class A (VTVT) - Vtv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update.
Q3 Revenue $3.0 Million.
Q3 Loss per Share $0.02.
Revenue is expected to be $1 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.